↓ Skip to main content
What is this page? Embed badge

Safety of pazopanib and sunitinib in treatment-naive patients with metastatic renal cell carcinoma: Asian versus non-Asian subgroup analysis of the COMPARZ trial

Overview of attention for article published in Journal of Hematology & Oncology, May 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

blogs
1 blog
twitter
1 X user

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
76 Mendeley
Summary Blogs X Dimensions citations
So far, Altmetric has seen 1 blog post.

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.

This page is provided by Altmetric.